baber/WOPTO huggingface dataset:
Patent NZ-270854-A (NZ)
Title: Active optical fibre for optical transmission amplification, doped with erbium and at least one secondary dopant
Inventor: MELI FAUSTO
IPC: H04B10/17
Filed: 1995-03-31
Abstract: The present invention relates to a telecommunication system including optical amplifiers connected in cascade, particularly adapted for a wavelength division multiplexing transmission, in which a combination of dopants in the fibre core enables a high signal/noise ratio to be achieved for all channels in a predetermined wavelength band, even in the presence of several simultaneously fed signals. <IMAGE>
Patent NZ-271318-A (NZ)
Title: Leukocyte cell preparations stabilised with heavy metal compounds
Inventor: GRANGER VIVIAN
IPC: G01N33/569
Filed: 1994-07-05
Abstract: The invention is directed to novel stabilized blood compositions and methods of stabilizing blood compositions for use in the quality control of analytical techniques. The novel blood compositions comprise leucocytes and an effective amount of an aged transition metal solution. The novel method comprises removing leucocytes from a blood composition to yield a depleted blood composition, stabilizing the leucocytes by treatment with an effective amount of a stabilizing agent comprising an aged transition metal solution, and then, adding the resultant stabilized leucocytes to the depleted blood composition or a second blood component composition.
Patent NZ-318300-A (NZ)
Title: Hydrolysis-promoting taxane hydrophobic derivatives
Inventor: MAYHEW ERIC
IPC: A61P35/00
Filed: 1996-09-12
Abstract: Provided herein is a taxane having a hydrocarbon attached at the 2' and/or 7 positions, the hydrocarbon's alpha position being occupied by a "hydrolysis-promoting group" ("HPG"). Substitution of an HPG for the methylene unit ordinarily occupying the alpha position allows for enhanced in vivo hydrolysis of the hydrocarbon-taxane bond, and hence, for enhanced taxane therapeutic activity. Also provided herein are taxane-containing compositions, and methods of administering taxanes to animals, including those afflicted with cancers.
Patent NZ-501230-A (NZ)
Title: Controller connected to game machine using combination electrical and optical fiber data cable
Inventor: TANAKA MAKOTO
IPC: A63F9/24
Filed: 1999-11-22
Abstract: The game main unit 11 and the game controller and status indicator unit 13 are connected for communications by a cable 14 incorporating electrical and optical conductors.  High-speed data transmission, which may cause electromagnetic interference, is performed via the optical conductors, and lesser speed data and power is transmitted between the units via the electrical conductors.  The controller includes the electrical/optical converter 20 and the converter 21 required on the other end of the cable is incorporated into the plug 15 connectable into the main game unit socket.
Patent NZ-501641-A (NZ)
Title: Ganglioside immunostimulating complexes and their use in treating cancer
Inventor: COX JOHN COOPER
IPC: A61P37/04
Filed: 1998-06-12
Abstract: Immunostimulating complexes comprising a saponin preparation, a sterol, a protein epitope, at least one or more gangliosides and optionally a phospholipid .The complexes are useful as a prophylactic and/or therapeutic agent in the treatment of tumours, and more particularly, melanomas
Patent NZ-502575-A (NZ)
Title: Gaming machine programmed to allow a predetermined minimum number of bets per line greater than a single bet per line
Inventor: GEORGE PAUL ANTHONY
IPC: G06F19/00
Filed: 2000-01-31
Abstract: A gaming machine comprising a display (106) for displaying betting data, a processor (102), and at least one request button (108) which allows a player to select a betting regime.  The processor (102) is programmed to allow a betting regime whereby a player can select only multiple credits per line.
Patent NZ-509274-A (NZ)
Title: Plant pot with porous plate separating two walled spaces, and hydrating material in second space
Inventor: VEN DEN ENDE PETER HUBERTUS EL
IPC: A01G27/06
Filed: 1999-07-19
Abstract: The invention relates to a plant pot comprising a first space (1) bounded by a first upright wall (4) and a second space (2) bounded by a second upright wall (5) and a bottom (7), which first and which second space (1,2) are separated from each other by a porous plate (9). The plant pot is according to the invention characterized in that a third space (3) bounded by a third upright wall (6) and a bottom (8) surrounds the second space (2), and in that the second space (2) serves to accommodate a moisture-retaining, hydrating but air-permeable material (12).
Patent NZ-509417-A (NZ)
Title: Novel peptides for use in immunotherapy of autoimmune diseases
Inventor: VERHEIJDEN GIJSBERTUS FRANCISC
IPC: A61K38/08
Filed: 1999-07-16
Abstract: Peptide  sequences that are able  to  induce  systemic immunological  tolerance,  in  particular  specific   T-cell tolerance,  and  their use in treating  autoimmune  diseases such as rheumatoid arthritis (RA).
Patent NZ-511537-A (NZ)
Title: Index tab label insert sheet laid onto backing sheet with patterned dry peel coating under tab label inserts that allows for removal of insert from insert sheet
Inventor: BAUMAN BRUCE D
IPC: G09F3/02
Filed: 1999-10-22
Abstract: A multi-layer index tab label insert sheet assembly with removable tab label inserts is disclosed. An exemplary label insert sheet includes a face stock 42 having a plurality of foldable tab label inserts 20, a release coated backing sheet 48 generally coextensive with the face stock sheet 42, a pressure sensitive adhesive coating between the face stock sheet and the release coated backing sheet to secure those sheets together, and a patterned varnish coating 50 underneath the index tab label inserts to allow the label inserts to be readily removed from the release coated backing sheet.
Patent NZ-512864-A (NZ)
Title: Triazole compounds with dopamine-D3-receptor affinity
Inventor: UNGER LILIANE
IPC: C07D403/04
Filed: 2000-01-12
Abstract: A triazole derivative or a salt thereof has the formula (I) and is useful for treating disease which respond to the influence of dopamine D3 receptor antagonists or agonists wherein: R1 is H, optionally substituted alkyl, cycloalkyl or phenyl; R2 is H, optionally substituted alkyl, alkoxy, alkylthio, alkenyl, alkynyl, cycloalkyl, halogen, CN, COOR3, CONR3R4, NR3R4, SO2R3, SO2NR3R4 or optionally substituted phenyl, naphthyl, or 5 or 6 membered heterocyclic radical having 1 to 4 heteroatoms of O, S or N; R3 and R4 is H, optionally substituted alkyl or phenyl; A is C4-10 alkylene or C3-10 alkylene having a Z group with Z being O, S, CONR3, COO, CO, cycloalkyl or a double or triple bond; B is a group of formula (II); X is CH2 or CH2CH2; R6, R7 or R8 are independently H, optionally substituted alkyl, OH, alkoxy, OCF3, OSO2CF3, SH, alkylthio, alkenyl, alkynyl, halogen, CN, NO2, CO2R3, SO2R3, SO2NR3R4, (wherein R3 and R4 are as defined above or together can form 5 to 7 membered optionally saturated heterocycle having 1 or 2 N atoms), CONR3R4, NHSO2R3, NR3R4 or optionally substituted 5 or 6 membered carbocyclic or heterocyclic aromatic or nonaromatic ring with the heterocyclic ring having 1 or 2 heteroatoms of O, N or S or two of R6 to R8 with the carbon atoms to which they are attached form phenyl, cyclopentyl or cyclohexyl fused to the phenyl ring with one or two CH or CH2 groups in the fused ring may be replaced by nitrogen, NH or N-alkyl.
Patent NZ-518253-A (NZ)
Title: Method for matching printing ink colors
Inventor: CHAN DOMINGO Q
IPC: G01J3/46
Filed: 2000-10-09
Abstract: A system for providing matching print colors, comprises: a first computer that can communicate with a second computer, the first computer comprises: (a) a database of data for predicting color data of ink formulations using an ink base color set, (b) a software program for selecting an ink formulation based on data for a desired ink, and (c) a software program for sending information to the second computer to display the color of the selected ink formulation on a color monitor connected to the second computer.
Patent NZ-522499-A (NZ)
Title: Infant simulator with a rocking request system
Inventor: JURMAIN RICHARD N
IPC: A63H3/24
Filed: 1998-12-04
Abstract: An infant simulator, comprising: (a) a mannequin; and (b) a rocking-request system within the mannequin for periodically effecting rocking-request episodes, including at least: a means for generating a perceptible rocking-request signal; and a means in communication with the rocking request means for detecting rocking of the mannequin and arresting the rocking-request signal when rocking is detected.
Patent NZ-523739-A (NZ)
Title: CDC25 phosphatase inhibitors
Inventor: BREZAK PANNETIER MARIE-CHRISTI
IPC: A61P35/00
Filed: 2001-07-26
Abstract: Use of a compound with the general formula (I), or a pharmaceutically acceptable salt, is described to be for preparing a medicament intended to inhibit cdc25 phosphatases. A represents a radical of the formula (A1) or (A2). If A is an (A1) radical then two of the groups selected from the list consisting of R1, R2, R3, R4 and R5 are hydrogen atoms and the other three groups are independently chosen from the list consisting of a hydrogen atom, a halogen atom, an alkyl, hydroxyl, alkoky, alkylcarbonyloxy, alkylthio and NR6R7 radical. If A is an (A2) radical then either R11 and one R group selected from the list consisting of R13, R14 and R15 are hydroxyl radicals, R12 is selected from hydrogen and hydroxyl, and the remaining R groups, in (A2) are hydrogen. X is selected from the list consisting of a -(CH2)q-, -(CH2)q-NH- and a -CO-(CH2)r- radical, q being an integer from 1 to 6 and r an integer from 0 to 6; B is selected from the list consisting of a -CO-, -NH-CO-(CH2)n- and a -(CH2)p- radical, n being an integer from 0 to 3 and p being an integer from 0 to 1; W is a hydrogen atom or an alkyl radical; and either (i) or (ii) applies: (i) when X represents a -(CH2)q- or -CO-(CH2)r- radical, then Y represents a radical of formula (II) in which R19 is selected from the list consisting of -SO-2-NR23R24, -NH-SO2-R25 and a -O-P(O)(OR26)(OR27) radical; and R20 is selected from a hydrogen atom, a halogen atom, an alkyl, alkoxy and an alkylthio radical; (ii) when X represents a -(CH2)q-NH- radical, then Y is a -SO2-R30 radical in which R30 is selected from an alkyl, haloalkyl radical, substituted aryl, substituted heteroaryl, substituted aralkyl, substituted heteroaralkyl, aryl, heteroaryl, aralkyl and heteroaralkyl. A proviso explains that the B-N(W)-X-Y group is not the radical of formula (III). Also disclosed are processes for the preparation of certain compounds with general formula (I). Intended use is for the treatment of conditions such as tumorous and non-tumorous proliferative diseases, parasitic diseases and viral infections.
Patent NZ-526717-A (NZ)
Title: Hydraulic energy storage systems
Inventor: FRAZER HUGH IVO
IPC: F15B21/14
Filed: 2001-11-28
Abstract: A hydraulic energy storage system for vehicles to provide higher efficiency, smaller package size, lower weight, unitary construction, durability and enhanced reliability while maintaining the capability to efficiently store and restore energy at high power levels.
Patent NZ-530752-A (NZ)
Title: Skin penetration enhancing components
Inventor: ORMEROD ANTHONY DAVID
IPC: A61K38/00
Filed: 1998-11-05
Abstract: A topical formulation for the treatment of a dermatological condition (such as psoriasis), comprising an immunosuppressive macrolide, which is SDZ ASM 981, wherein it further comprises a permeation modulator, and wherein the permeation modulator and the macrolide are present in relative amounts such that when a therapeutic amount is applied to skin a minimal systemic effects are produced. (62) Divided out of 520449
Patent NZ-532625-A (NZ)
Title: Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
Filed: 2002-04-11
Abstract: Methods of determining a prognosis or a treatment regime for a patient diagnosed with an acute coronary syndrome comprising: contacting all or a portion of a sample from the patient with a first antibody that binds cardiac troponin I; contacting all or a portion of a sample from the patient with a second antibody that binds BNP and/or related markers related to BNP; determining the binding of the cardiac troponin I and the BNP and /or marker related to BNP to the first and second antibodies; and relating the binding to the patient's prognosis.
Patent NZ-533311-A (NZ)
Title: New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
Inventor: BHUNIYA DEBNATH
IPC: A61P25/28
Filed: 2002-12-02
Abstract: Disclosed are antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula I in which the substituents are as described in the specification. In particular, disclosed are compounds which are predominantly PPAR alpha agonists, their novel intermediates, processes for their preparation, their use in the preparation of compounds of formula I and their use as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds.
Patent NZ-535684-A (NZ)
Title: Use of a GLP-1 (glucagon like peptide-1) compound to treat gastroparesis by increasing gastric emptying
Inventor: JAKUBOWSKI JOSEPH ANTHONY
IPC: A61K38/26
Filed: 2003-03-27
Abstract: Described is the use of GLP-1 (Glucagon-like peptide-1) compounds to treat gastroparesis. Patients with gastroparesis generally experience a delay in gastric emptying. GLP-1 compounds can be used to regulate gastric emptying in these patients.
Patent NZ-540399-A (NZ)
Title: Method for production of alkyl esters from a mixture of glycerides and fatty acids
Inventor: MUSKETT RAYMOND
Filed: 2002-11-27
Abstract: A method for production of alkyl esters from a mixture of glycerides and free fatty acids, originating primarily from grease trap waste, is disclosed. The mixture is first solvated in a low boiling point alcohol and then the pH of the solution is adjusted to about 1 to 2 by addition of an acid to effect acid-catalysed alkyl esterification. The acidic solution is then treated with a concentrated alkoxide solution to raise the pH of the solution about pH 12 to effect base-catalysed transesterification of glycerides contained in the mixture. The resulting solution is then treated with an acid to decrease the pH of the solution to about 2 to effect acid-catalysed esterification of residual saponified by-products. The alcohol solvent is removed by distillation or other suitable techniques and the resulting alkyl esters are separated from any remaining residues and neutralised of residual acids.
Patent NZ-543471-A (NZ)
Title: A cellular minigrid
Inventor: CHAMBERS COLIN
IPC: H02J3/00
Filed: 2004-04-15
Abstract: A system for transferring a resource within an area having a plurality of regions is disclosed. The system comprises: (a) determining means operable to determine whether any one or more of the regions requires an amount of the resource; (b) requesting means operable to issue a request to one of the regions for the amount of the resource; and (c) transferring means operable to transfer the resource from one of the regions to any one or more of the regions, such that any one or more of the regions are supplied with their required amount of resource.
Patent NZ-544193-A (NZ)
Title: Use of poly-aminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis
Inventor: LOMBARDI PAOLO
IPC: A61K9/00
Filed: 2004-05-13
Abstract: A combination of a distamycin analogue of formula I and cyclodextrin is useful in the treatment of endoparasitosis in animals.
Patent NZ-546732-A (NZ)
Title: Method of inhibiting remnant lipoprotein production
Inventor: OKAMOTO HIROSHI
IPC: A61K31/00
Filed: 2004-09-24
Abstract: Disclosed is the use of cholesterol ester transfer protein (CETP) inhibitors of formulae (VII) and (VIII), including S-{2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl}-2-methylpropanethioate, which is known as JTT-705, in the preparation of a medicament for the treatment or prevention of hyper-remnant lipoproteinemia.
Patent NZ-551021-A (NZ)
Title: Guanidine based composition and system for generating energy
Inventor: VAN VECHTEN JAMES ALDEN
IPC: C01B33/04
Filed: 2005-05-03
Abstract: A method and apparatus for generating energy from a composition containing guanidine (CH5N3) and a method and apparatus for providing the composition containing guanidine using energy are described. Particularly disclosed is a method of generating energy from a composition containing from about 10% to about 100% by weight of the composition of guanidine, wherein the method comprises: (a) reacting the composition with water to form ammonia and carbon dioxide; and (b) oxidizing the ammonia formed in step (a) to form water and nitrogen generating energy. The method and apparatus are used to generate energy for use in stationary and mobile applications.
Patent NZ-565560-A (NZ)
Title: Improved dough moulder with formed channels or troughs on lower section of pressure rolling board
Inventor: WILLETT PAUL EATON
Filed: 2008-01-30
Abstract: A dough moulder is disclosed including a dough conveyor operable to receive a strip of dough, the conveyor having a first run operable to co-operate with a curling element to curl or roll the dough strip into a dough piece and a second run operable with a pressure rolling board to mould the dough piece, wherein the pressure rolling board has an upper section and a lower section, the lower section including a plurality of formed channels or troughs.
Patent NZ-573585-A (NZ)
Title: Stator casing where the inner surface faces form a polygon and each face has a groove to reduce friction
Inventor: TEKNEYAN MIKAEL
IPC: F04C2/107
Filed: 2007-05-10
Abstract: A stator casing (10) for an eccentric worm pumps is disclosed. The stator casing (10) includes an inner surface (12) consisting of a series of inner surface faces. The inner surface faces are arranged so that, in a cross-section of the stator casing (10) in a plane perpendicular to the longitudinal axis, the inner surface forms a polygon. At least one of the inner surface faces includes at least one groove (16) which reduces the adhesive effect between the stator casing (10) and an elastic lining which moves axially within the casing.
Patent NZ-577841-A (NZ)
Title: A method and roller die made using the method which has a steel and non-ferrous metal sleeve
Inventor: VIGURS STANLEY WALTER
IPC: B41C1/045
Filed: 2007-12-04
Abstract: A method of making an impression die is disclosed. The method has the steps of providing a substantially planar bendable bimetal plate (10) consisting of copper (non-ferrous) and steel bonded together, forming a relief pattern (14) in the surface of the copper for example by an etching process, forming the plate into a non-planar sleeve with the copper on the outside and joining the free edges of the sleeve together. Preferably the free edges of the sleeve (10) are joined together while the sleeve is mounted on a metal mandrel.
Patent NZ-578293-A (NZ)
Title: 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
Inventor: CORDI ALEXIS
IPC: A61P25/16
Filed: 2007-12-28
Abstract: Disclosed is 8-Cyclopropy1-3-[2-(3-fluorophenypethyl]-7,8-dihydro-3H-[1,3]oxazino [6,5-g][1,2,3]benzotriazine-4,9-dione, or a pharmaceutically acceptable addition salt of an acid or base thereof. Also disclosed is the use of the said compound for treating schizophrenia, Parkinson's disease, ADHD or Alzheimer's disease.
Patent NZ-579398-A (NZ)
Title: Fruit turned then stopped in particular orientation
Inventor: FLEMMER CLAIRE LORRAINE
IPC: B65B35/00
Filed: 2010-12-01
Abstract: An apparatus for singulating, orienting and packing objects. The apparatus includes means (1, 2, 3) to tumble at least one object within a predetermined space, means (4) to determine the orientation of at least one object whilst it is being tumbled, and means to terminate the tumbling at an instant when the object(s) is determined to be in a preferred orientation to be picked up by a mechanical picker (5). The means to determine the orientation of the object(s) includes means to generate a planar beam of light to strike the objects(s) and means to progressively analyse the images of the intersections between the planar light beam and the object(s), as recorded by a camera(s) whilst the object is being tumbled and after it has been arrested in order to evaluate the instantaneous orientation of the object(s).
Patent NZ-581419-A (NZ)
Title: Modulators of cystic fibrosis transmembrane conductance regulator
Inventor: BINCH HAYLEY
IPC: A61K31/407
Filed: 2008-05-23
Abstract: The disclosure relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), compositions thereof, and methods therewith. The disclosure particularly thieno-pyridine derivatives of represented by formula (I) or formula (II) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification.
Patent NZ-588935-A (NZ)
Title: Intraocular lens having a surface configured as an aspheric lens and a surface configured as a toric lens
Inventor: HAMLIN MICHAEL
IPC: A61F2/16
Filed: 2009-05-05
Abstract: 588935 An injectable ophthalmic intraocular lens device (10) is disclosed. The device comprises an ophthalmic lens with an anterior surface (14) and a posterior surface (16) and one or more haptics (20) coupled to the ophthalmic lens. One of the posterior or anterior surfaces is shaped so that the ophthalmic lens is configured as an aspheric lens and one of the posterior or anterior surfaces is shaped so that the ophthalmic lens is configured as a toric lens. The ophthalmic lens has a selected edge thickness at the 45 degree meridians of between 0.2 and 0.3 mm and varies periodically and sinusoidally around the toric lens.
Patent NZ-589691-A (NZ)
Title: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Inventor: LERICHE CAROLINE
IPC: A61P1/18
Filed: 2009-04-08
Abstract: Disclosed herein are thiazole derivatives of general formula (I), wherein the substituents are as defined in the specification, processes for their preparation, compositions/medicaments comprising said compounds and uses thereof. Said compounds are useful as selective inhibitors of enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11-â-HSD-1) and as such are useful in the treatment and/or prevention of metabolic syndrome, diabetes, insulin resistance, low glucose tolerance, hyperglycemia, obesity and weight-related disorders, lipid disorders, glaucoma, osteoporosis, glucocorticoid-mediated effects on neuronal function, cognitive disorders, anxiety, depression, neurodegenerative disease, immune disorders (such as tuberculosis, leprosy or psoriasis), hypertension, atherosclerosis and its sequelae, vascular restenosis, cardiovascular diseases, pancreatitis, retinopathy, neuropathy and nephropathy. Specifically preferred compounds include: · 3,3-Dimethyl-1-{ 4-{ 4-(octahydro-quinoline-1-carbonyl)-thiazol-2-yl]-piperidin-1-yl} -butan-1-one; · { 2-[1-(4-Fluoro-benzoyl)-piperidin-4-yl]-thiazol-4-yIH octahydro-quinolin-1-yl)-methanone; · 2-(4-Methoxy-phenyl)-1-{ 4-[4-(piperidine-1-carbonyl)-thiazol-2-yl]piperidin-1-yl} -ethanone; · 4-[4-(Octahydro-quinoline-1-carbonyl)-thiazol-2-yl]-piperidine-1-carboxylic acid isopropylamide; · 2-[1-(Butane-1-sulfonyl)-piperidin-4-yl]-thiazole-4-carboxylic acid cyclohexyl-cyclopropyl-amide; · 2-[1-(4-Fluoro-benzenesulfonyl)-piperidin-4-yl]-thiazole-4-carboxylic acid cyclohexyl-cyclopropyl-amide; · { 2-[1-(2-Cyclohexyl-ethyl)-piperidin-4-yl]-thiazol-4-yl} -(octahydroquinolin-1-yl)-methanone.
Patent NZ-592726-A (NZ)
Title: Amnion derived adherent cells
Inventor: FRANCKI ALEKSANDAR
IPC: A61K35/12
Filed: 2009-11-19
Abstract: Disclosed is an isolated amnion derived adherent cell, wherein said cell is adherent to tissue culture plastic, and wherein said cell is OCT-4- (octamer binding protein 4) as determined by RT-PCR and HLA-G-, as determined by RT-PCR.